AKT1 and breast cancer: The central mechanism whereby IGF-I contributes to breast cancer formation and progression is mediated through the IGF-I Receptor (IGF-IR) on the breast cell membrane which subsequently activates signal transduction via the MAPK and PI3K/Akt pathways [15].